Methamphetamine Abuse Prevention Act of 2005

H.R. 1446, the Methamphetamine Abuse Prevention Act of 2005, proposes stricter federal controls on the sale and production of chemicals used to manufacture methamphetamine, specifically pseudoephedrine and phenylpropanolamine. For everyday consumers, the bill would lower the legal limit for retail purchases of these common cold and allergy medications and remove exemptions for "blister pack" packaging, meaning more transactions would be subject to tracking and regulation.

Beyond retail restrictions, the bill authorizes funding for law enforcement training, the cleanup of toxic lab sites, and the hiring of specialized prosecutors to handle methamphetamine cases. It also focuses on public health by providing grants for drug treatment programs—particularly in rural areas—and establishing "rapid response teams" to support children discovered in homes where methamphetamine is produced or used.